Xintela AB (OSTO:XINT) Days Payable : 0.00 (As of Sep. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Xintela AB Days Payable?

Xintela AB's average Accounts Payable for the three months ended in Sep. 2024 was kr5.07 Mil. Xintela AB's Cost of Goods Sold for the three months ended in Sep. 2024 was kr0.00 Mil.

The historical rank and industry rank for Xintela AB's Days Payable or its related term are showing as below:

OSTO:XINT's Days Payable is not ranked ^*
in the Biotechnology industry.
Industry Median: 127.37
* Ranked among companies with meaningful Days Payable only.

Xintela AB's Days Payable stayed the same from Sep. 2023 (0.00) to Sep. 2024 (0.00). stayed the same

Xintela AB Days Payable Historical Data

The historical data trend for Xintela AB's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xintela AB Days Payable Chart

Xintela AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

Xintela AB Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Days Payable	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Xintela AB's Days Payable

For the Biotechnology subindustry, Xintela AB's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Xintela AB's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Xintela AB's Days Payable distribution charts can be found below:

* The bar in red indicates where Xintela AB's Days Payable falls into.

Xintela AB Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Xintela AB's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (8.846	+	7.483)	/	2 )	/	0	*	365
=	8.1645					/	0	*	365
=	N/A

Xintela AB's Days Payable for the quarter that ended in Sep. 2024 is calculated as:

	Days Payable (Q: Sep. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Jun. 2024 )	+	Accounts Payable (Q: Sep. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Sep. 2024 )	*	Days in Period
=	( (4.828	+	5.318)	/	2 )	/	0	*	365 / 4
=	5.073					/	0	*	365 / 4
=	N/A

Xintela AB Days Payable Related Terms

Thank you for viewing the detailed overview of Xintela AB's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Xintela AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Xintela AB (OSTO:XINT) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

Medicon Village, Lund, SWE, 22381

Website

https://www.xintela.se

Xintela AB is a biomedical company that develops stem cell-based treatments with a focus on osteoarthritis and hard-to-heal leg wounds as well as, through the wholly-owned subsidiary Targinta, targeted antibody-based treatments for aggressive cancers such as triple-negative breast cancer and the brain tumor glioblastoma.

Xintela AB Headlines

No Headlines